|
|
|
Insider
Information: |
Schimmel Paul |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,717,702 |
|
Indirect Shares
|
1,312,785 |
|
|
Direct
Value |
$100,031,509 |
|
|
Indirect Value
|
$46,568,243 |
|
|
Total
Shares |
3,030,487 |
|
|
Total
Value |
$146,599,752 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2015-03-19 |
4 |
AS |
$120.00 |
$1,086,360 |
D/D |
(9,053) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2014-01-13 |
4 |
AS |
$85.36 |
$1,280,400 |
D/D |
(15,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
officerTitle |
|
2006-01-31 |
4 |
B |
$13.00 |
$1,300,000 |
I/I |
100,000 |
338,088 |
2.1 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2015-04-21 |
4 |
AS |
$130.02 |
$1,300,200 |
D/D |
(10,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2018-03-13 |
4 |
OE |
$30.09 |
$1,369,927 |
D/D |
27,823 |
27,823 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2014-10-28 |
4 |
AS |
$95.00 |
$1,425,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2014-12-08 |
4 |
AS |
$105.00 |
$1,575,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2021-09-20 |
4 |
B |
$8.00 |
$2,000,000 |
D/D |
250,000 |
252,890 |
2.39 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2018-03-13 |
4 |
AS |
$150.00 |
$4,173,450 |
D/D |
(27,823) |
0 |
0 |
- |
|
84 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|